Peter Graham - Jun 10, 2021 Form 4 Insider Report for ANTARES PHARMA, INC. (ATRS)

Role: EVP General Counsel, Secretary
Signature: /s/Lisa M. Kallebo as attorney-in-fact for Peter J. Graham
Stock symbol: ATRS
Transactions as of: Jun 10, 2021
Transactions value $: $211,791
Form type: 4
Date filed: 6/14/2021, 06:21 PM
Previous filing: Jun 10, 2021
Next filing: Feb 18, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ATRS	Common Stock	Award	$380K	+86K	+15.74%	$4.42	632K	Jun 10, 2021	Direct	F1
transaction	ATRS	Common Stock	Tax liability	-$102K	-23K	-3.64%	$4.45	609K	Jun 11, 2021	Direct	F2
transaction	ATRS	Common Stock	Tax liability	-$65.8K	-14.8K	-2.43%	$4.45	594K	Jun 13, 2021	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ATRS	Stock Option (right to buy)	Award	$0	+164K		$0.00	164K	Jun 10, 2021	Common Stock	164K	$4.42	Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents grant of restricted stock units made under the Antares Pharma, Inc. Equity Compensation Plan. The shares vest in three equal annual installments from the date of grant.
F2	Represents the payment of tax liability using a portion of securities received from the company in connection with the vesting of a previously granted restricted stock unit award. The shares of common stock reported herein were withheld by the company to cover tax liability and not actually sold.
F3	Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. Equity Compensation Plan.
F4	The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date.